-
will focus on (but not limited to) implementing graph neural networks, network biology approaches, multimodal learning techniques, and explainable AI methodologies. Role Summary The post holder will
-
innovative molecular biology and diagnostic technologies, this is your opportunity to make a meaningful impact in combating one of the world's most persistent infectious diseases. The successful candidate will
-
opportunity to learn more about biomaterials and polymeric adhesives. You should have completed (or be near to completion) an experimental PhD in either biology, biochemistry, chemistry or closely related area
-
a relevant field such as Biotechnology, Molecular Biology, Biochemistry, Biophysics or other relevant scientific field, with proven relevant experience in the Life Science industry or equivalent
-
hypothyroidism (CH), identifying known and novel genetic causes of CH in affected patients using candidate gene and exome/genome sequencing-based approaches. They then investigate the biology associated with
-
the field of microbiology. Significant experience with microbiology and microbial genomics and/or microbial bioinformatics is required. Able to perform molecular biology laboratory work applying new
-
molecular biology and protein-based laboratory techniques and CRISPR. Experience with single molecule DNA fibre analysis is preferable. Role Summary To plan, carry out and develop laboratory-based research
-
Job Description Position Details Clinical Immunology Service, School of Infection, Inflammation and Immunology, College of Medicine and Health Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £46,735 to £55,755 with potential...
-
Job Description Position Details Clinical Immunology Service, School of Infection, Inflammation and Immunology, College of Medicine and Health Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range £46,735 to £55,755 with potential...
-
. This will be achieved using cutting-edge cell and molecular biology approaches including CRISPR/Cas9-mediated gene editing, advanced microscopy techniques and analysis of synthetic lethality. The successful